{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:12:03Z","timestamp":1771654323358,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,31]]},"DOI":"10.7759\/cureus.19163","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T14:57:21Z","timestamp":1635692241000},"source":"Crossref","is-referenced-by-count":3,"title":["Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database"],"prefix":"10.7759","author":[{"given":"Mary","family":"Dahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J","family":"Aurit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter T","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Gootee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pathology and genetics of tumours of soft tissue and bone","author":"Fletcher CDM","year":"2002","unstructured":"Fletcher CDM, Unni KK, Mertens F, World Health Organization. Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours. Fletcher CDM, Unni KK, Mertens F (ed): IARC Press, Lyon; 2002. 100-107."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases","volume":"119","author":"Toro JR","year":"2006","unstructured":"Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer. 2006, 119:2922-30. 10.1002\/ijc.22239","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181ef70b6","article-title":"Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period","volume":"34","author":"Bahrami A","year":"2010","unstructured":"Bahrami A, Folpe AL. Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010, 34:1504-13. 10.1097\/PAS.0b013e3181ef70b6","journal-title":"Am J Surg Pathol"},{"key":"ref4","article-title":"Primary ovarian fibrosarcoma: a case report and review of the literature","volume":"11","author":"Ozdem\u0131r O","year":"2016","unstructured":"Ozdem\u0131r O, Sar\u0131 ME, Sen E, Ilg\u0131n BU, Guresc\u0131 S, Atalay CR. Primary ovarian fibrosarcoma: a case report and review of the literature. J Exp Ther Oncol. 2016, 11:225-35.","journal-title":"J Exp Ther Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e318256da58","article-title":"Low-grade fibromyxoid sarcoma of the vulva:  a case report","volume":"17","author":"VanSandt AM","year":"2013","unstructured":"VanSandt AM, Bronson J, Leclair C, Mansoor A, Goetsch M. Low-grade fibromyxoid sarcoma of the vulva:  a case report. J Low Genit Tract Dis. 2013, 17:79-81. 10.1097\/LGT.0b013e318256da58","journal-title":"J Low Genit Tract Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2015.02.007","article-title":"Low-grade fibromyxoid sarcoma of the sigmoid colon","volume":"98","author":"Mendoza AS","year":"2015","unstructured":"Mendoza AS, O'Leary MP, Peng SK, Petrie BA, Li AI, French SW. Low-grade fibromyxoid sarcoma of the sigmoid colon. Exp Mol Pathol. 2015, 98:300-3. 10.1016\/j.yexmp.2015.02.007","journal-title":"Exp Mol Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2012.11.004","article-title":"Low-grade fibromyxoid sarcoma: an unusual cardiac location","volume":"22","author":"Ferlosio A","year":"2013","unstructured":"Ferlosio A, Doldo E, Polisca P, Orlandi A. Low-grade fibromyxoid sarcoma: an unusual cardiac location. Cardiovasc Pathol. 2013, 22:e15-7. 10.1016\/j.carpath.2012.11.004","journal-title":"Cardiovasc Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2350\/14-05-1487-CR.1","article-title":"Primary low-grade fibromyxoid sarcoma of the kidney in a child with the alternative EWSR1-CREB3L1 gene fusion","volume":"17","author":"Rubinstein JC","year":"2014","unstructured":"Rubinstein JC, Visa A, Zhang L, Antonescu CR, Christison-Lagay ER, Morotti R. Primary low-grade fibromyxoid sarcoma of the kidney in a child with the alternative EWSR1-CREB3L1 gene fusion. Pediatr Dev Pathol. 2014, 17:321-6. 10.2350\/14-05-1487-CR.1","journal-title":"Pediatr Dev Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4274\/tjod.73626","article-title":"Low-grade fibromyxoid sarcoma of the vagina: a tumor, not previously reported at this site","volume":"11","author":"G\u00fcd\u00fcc\u00fc N","year":"2014","unstructured":"G\u00fcd\u00fcc\u00fc N, \u00c7oban \u0130, Ba\u015fs\u00fcll\u00fc N, G\u00f6nen\u00e7 G, Ayd\u0131nl\u0131 K. Low-grade fibromyxoid sarcoma of the vagina: a tumor, not previously reported at this site. Turk J Obstet Gynecol. 2014, 11:196-7. 10.4274\/tjod.73626","journal-title":"Turk J Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20136","article-title":"Current diagnostics and treatment of fibrosarcoma - perspectives for future therapeutic targets and strategies","volume":"8","author":"Augsburger D","year":"2017","unstructured":"Augsburger D, Nelson PJ, Kalinski T, et al.. Current diagnostics and treatment of fibrosarcoma - perspectives for future therapeutic targets and strategies. Oncotarget. 2017, 8:104638-53. 10.18632\/oncotarget.20136","journal-title":"Oncotarget"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali PG","year":"2018","unstructured":"Casali PG, Abecassis N, Aro HT, et al.. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018, 29:51-67. 10.1093\/annonc\/mdy096","journal-title":"Ann Oncol"},{"key":"ref12","article-title":"Bone and Soft Tissue Pathology: A Volume in the Foundations in Diagnostic Pathology Series","author":"Folpe AL","year":"2009","unstructured":"Folpe AL, Inwards CY. Bone and Soft Tissue Pathology: A Volume in the Foundations in Diagnostic Pathology Series. Goldblum JR (ed): Elsevier, Amsterdam, Netherlands; 2009."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8284931","article-title":"Nomograms predict overall survival and cancer-speci\ufb01c survival in patients with fibrosarcoma: a SEER-based study","volume":"2020","author":"Xiang GH","year":"2020","unstructured":"Xiang GH, Zhu JJ, Ke CR, et al.. Nomograms predict overall survival and cancer-speci\ufb01c survival in patients with fibrosarcoma: a SEER-based study. J Oncol. 2020, 2020:8284931. 10.1155\/2020\/8284931","journal-title":"J Oncol"},{"key":"ref14","article-title":"Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines","volume":"48","author":"Slovak ML","year":"1988","unstructured":"Slovak ML, Hoeltge GA, Dalton WS, Trent JM. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res. 1988, 48:2793-7.","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/107327480501200102","article-title":"Diagnosis, classification, and management of soft tissue sarcomas","volume":"12","author":"Mankin HJ","year":"2005","unstructured":"Mankin HJ, Hornicek FJ. Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control. 2005, 12:5-21. 10.1177\/107327480501200102","journal-title":"Cancer Control"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28708","article-title":"Socioeconomic and health care coverage disparities in children, adolescents, and young adults with sarcoma","volume":"67","author":"Westermann C","year":"2020","unstructured":"Westermann C, Weller J, Pedroso F, Canner J, Pratilas CA, Rhee DS. Socioeconomic and health care coverage disparities in children, adolescents, and young adults with sarcoma. Pediatr Blood Cancer. 2020, 67:e28708. 10.1002\/pbc.28708","journal-title":"Pediatr Blood Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2017.05.017","article-title":"Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base","volume":"49","author":"Miller BJ","year":"2017","unstructured":"Miller BJ, Gao Y, Duchman KR. Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base. Cancer Epidemiol. 2017, 49:112-7. 10.1016\/j.canep.2017.05.017","journal-title":"Cancer Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/CORR.0000000000000889","article-title":"Is there an association between insurance status and survival and treatment of primary bone and extremity soft-tissue sarcomas? A SEER database study","volume":"478","author":"Smartt AA","year":"2020","unstructured":"Smartt AA, Jang ES, Tyler WK. Is there an association between insurance status and survival and treatment of primary bone and extremity soft-tissue sarcomas? A SEER database study. Clin Orthop Relat Res. 2020, 478:527-36. 10.1097\/CORR.0000000000000889","journal-title":"Clin Orthop Relat Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.11087","article-title":"Associations of socioeconomic status, public vs private insurance, and race\/ethnicity with metastatic sarcoma at diagnosis","volume":"3","author":"Diessner BJ","year":"2020","unstructured":"Diessner BJ, Weigel BJ, Murugan P, Zhang L, Poynter JN, Spector LG. Associations of socioeconomic status, public vs private insurance, and race\/ethnicity with metastatic sarcoma at diagnosis. JAMA Netw Open. 2020, 3:e2011087. 10.1001\/jamanetworkopen.2020.11087","journal-title":"JAMA Netw Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25095","article-title":"Adult soft tissue sarcoma and time to treatment initiation: an analysis of the National Cancer Database","volume":"117","author":"Curtis GL","year":"2018","unstructured":"Curtis GL, Lawrenz JM, George J, et al.. Adult soft tissue sarcoma and time to treatment initiation: an analysis of the National Cancer Database. J Surg Oncol. 2018, 117:1776-85. 10.1002\/jso.25095","journal-title":"J Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32377","article-title":"Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer","volume":"125","author":"Wang S","year":"2019","unstructured":"Wang S, Lai S, von Itzstein MS, et al.. Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer. Cancer. 2019, 125:4252-9. 10.1002\/cncr.32377","journal-title":"Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.19697","article-title":"Association of type of treatment facility with overall survival after a diagnosis of head and neck cancer","volume":"3","author":"Carey RM","year":"2020","unstructured":"Carey RM, Fathy R, Shah RR, et al.. Association of type of treatment facility with overall survival after a diagnosis of head and neck cancer. JAMA Netw Open. 2020, 3:e1919697. 10.1001\/jamanetworkopen.2019.19697","journal-title":"JAMA Netw Open"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07657-5","article-title":"Facility type is associated with margin status and overall survival of patients with resected intrahepatic cholangiocarcinoma","volume":"26","author":"Lee GC","year":"2019","unstructured":"Lee GC, Gamblin TC, Fong ZV, et al.. Facility type is associated with margin status and overall survival of patients with resected intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2019, 26:4091-9. 10.1245\/s10434-019-07657-5","journal-title":"Ann Surg Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000533623.60399.1b","article-title":"Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers?","volume":"477","author":"Lazarides AL","year":"2019","unstructured":"Lazarides AL, Kerr DL, Nussbaum DP, et al.. Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers?. Clin Orthop Relat Res. 2019, 477:718-27. 10.1097\/01.blo.0000533623.60399.1b","journal-title":"Clin Orthop Relat Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73899-primary-site-and-other-prognostic-factors-for-fibrosarcoma-an-analysis-of-the-national-cancer-database","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:46Z","timestamp":1707507166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73899-primary-site-and-other-prognostic-factors-for-fibrosarcoma-an-analysis-of-the-national-cancer-database"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.19163","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,31]]}}}